NEW YORK (GenomeWeb News) – Australian biomarker-based diagnostic firm Healthlinx today announced a distribution deal to begin offering its OvPlex test in India in the third quarter.

The deal between Healthlinx and distribution partners Inex Innovations Exchange and Metropolis Healthcare will make OvPlex, an ovarian cancer diagnostic test, available initially in Mumbai beginning Aug. 1, with expansion into other major Indian cities in the months to follow.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.